Despite the relatively high frequency of elevated ESR1 copy numbers in breast tumors [18], the clinical relevance of ESR1 gene amplification as a prognostic or predictive biomarker is not clear and requires further study [15]. This evidence concerns the gene ESR1 and breast neoplasm.